Previous close | 737.20 |
Open | 775.00 |
Bid | 773.00 x 1200 |
Ask | 776.69 x 1100 |
Day's range | 767.66 - 795.50 |
52-week range | 414.31 - 800.78 |
Volume | |
Avg. volume | 3,119,585 |
Market cap | 742.643B |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 126.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 5.20 (0.71%) |
Ex-dividend date | 14 Feb 2024 |
1y target est | N/A |
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
The market rally stumbled ahead of the Fed meeting. Amazon and AI plays Super Micro and AMD reported earnings late.
Guidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture.